Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. QCOM
6. ACN
7. AZN
8. ROIV
9. AAPL
10. HOOD

Go back to Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update

Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 16c, Misses on Revenue; Offers FY24 Revenue Guidance

May 8, 2024 4:44 PM EDT

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 EPS of $0.38, $0.16 better than the analyst estimate of $0.22. Revenue for the quarter came in at $98.44 million versus the consensus estimate of $99.03 million.

GUIDANCE:

Catalyst Pharmaceuticals sees FY2024 revenue of $455-475 million, versus the consensus of... More